Oral LD50 determination in rats and mice is the cornerstone acute toxicity study used to quantify the lethal potential of chemical, pharmaceutical, agrochemical, and food-related substances after a single oral dose. Modern GLP-compliant, accredited third-party laboratories conduct this test under internationally recognized protocols such as OECD Test Guidelines 420, 423, and 425, as well as national standards including GB 15193.3, GB/T 21603, and EPA OPPTS 870.1100. This article explains the scientific principles, animal models, dose-setting strategies, statistical approaches, and regulatory applications of acute oral toxicity testing in rodents.
Technical Overview
Definition and Significance of LD50
LD50 (median lethal dose) is a statistically derived estimate of the single dose of a test substance, expressed in mg per kg of body weight, that is expected to cause death in 50% of a group of test animals following oral administration. Oral LD50 determination in rats and mice is the most widely performed acute systemic toxicity study, providing the fundamental data needed to characterize the intrinsic hazard of a substance, establish toxicity classification categories, and support hazard labeling and risk assessment decisions.
Regulatory Framework
The classical LD50 protocol described in the original OECD Test Guideline 401 was officially deleted in 2002 due to animal welfare concerns. It has been replaced by refined, animal-sparing alternatives that estimate the LD50 or assign a toxicity category with substantially fewer animals, in line with the 3Rs principle (Replacement, Reduction, and Refinement). Current testing is performed according to the following framework:
- OECD Test Guideline 420: Acute Oral Toxicity – Fixed Dose Procedure
- OECD Test Guideline 423: Acute Oral Toxicity – Acute Toxic Class Method
- OECD Test Guideline 425: Acute Oral Toxicity – Up-and-Down Procedure
- GB 15193.3: National food safety standard for acute oral toxicity testing
- GB/T 21603: Chemicals – Test method for acute oral toxicity
- EPA OPPTS 870.1100: Acute oral toxicity testing guideline
- GHS (Globally Harmonized System of Classification and Labelling of Chemicals) for hazard categorization
Animal Models and Welfare
Commonly used rodent models include Sprague-Dawley and Wistar rats, and Kunming (KM), ICR, or BALB/c mice. Young adult animals, typically 6 to 12 weeks of age with body weights within plus or minus 20% of the group mean, are used after an acclimation period of at least 5 to 7 days. Animals are housed under controlled environmental conditions of approximately 20 to 25 degrees Celsius, 40% to 70% relative humidity, and a 12-hour light/dark cycle. All studies must be reviewed and approved by an institutional animal care and ethics committee, and humane endpoints are strictly applied to minimize suffering. Studies supporting regulatory submissions are performed in facilities operating under the OECD Principles of Good Laboratory Practice (GLP).
Testing Samples
Industrial Chemicals and New Chemical Substances
Fine chemicals, intermediates, monomers, surface-active agents, dyes, catalysts, nanomaterials, and newly synthesized substances requiring notification under chemical inventories such as REACH in the European Union or new chemical substance registration in China.
Agrochemicals
Technical-grade active ingredients (TC/TGAI) and formulated products including emulsifiable concentrates, suspension concentrates, wettable powders, water-dispersible granules, and seed treatment agents intended for pesticide registration.
Pharmaceutical and Biotechnology Products
Small-molecule drug candidates, impurities, degradation products, excipients, extracts, and biologics evaluated during preclinical development for maximum tolerated dose and acute hazard characterization.
Food-Related Substances
Food additives, novel food ingredients, functional food components, food contact materials, feed additives, and genetically modified food products requiring safety evaluation under the national food safety standard series.
Consumer and Household Products
Cleaning agents, disinfectants, biocides, cosmetics ingredients, air care products, and other household chemical formulations requiring acute hazard classification.
Sample Submission Requirements
For a standard two-species study, a minimum of 20 to 50 grams (or milliliters) of test substance is generally recommended, depending on the expected toxicity and dose range. Submissions should be accompanied by a certificate of analysis, safety data sheet, purity and composition information, physical form, solubility data, stability information, and storage requirements to support dose formulation and analytical verification.
Testing Items
A complete acute oral toxicity study delivers the following results and data points:
- Point estimate of the oral LD50 with 95% confidence interval, where applicable
- Toxicity category assignment according to GHS criteria (or relevant national classification schemes)
- Mortality incidence, time-to-death, and dose-response relationship
- Detailed clinical observations including CNS effects, autonomic signs, respiratory and cardiovascular changes, tremors, convulsions, salivation, lethargy, and coma
- Body weight measurements on dosing day, weekly intervals, and study termination
- Gross necropsy findings for all animals, including target organ indications
- Maximum tolerated dose (MTD) or no-mortality-at-limit-dose conclusion for low-toxicity substances
- Dose formulation analysis including homogeneity, concentration verification, and stability where required
- Auditable study report suitable for regulatory submission
Testing Methods
Study Preparation and Dose Administration
Test substance is administered as a single oral gavage dose using a suitable vehicle such as purified water, 0.5% sodium carboxymethyl cellulose (CMC-Na), corn oil, or polyethylene glycol 400. Rats are fasted overnight (approximately 16 hours) and mice for approximately 3 to 4 hours prior to dosing, with water provided ad libitum. The gavage volume is typically limited to 10 mL/kg body weight for aqueous formulations and up to 20 mL/kg for oil-based vehicles. Dose levels are selected based on existing structure-activity data, literature, or a preliminary sighting study.
Fixed Dose Procedure (OECD TG 420)
This method uses predefined dose levels of 5, 50, 300, and 2000 mg/kg and evaluates evident toxicity rather than lethality as the primary endpoint. A small sighting study identifies an appropriate starting dose, followed by a main study typically using 5 animals per sex. The outcome classifies the substance without precise LD50 calculation, significantly reducing animal distress.
Acute Toxic Class Method (OECD TG 423)
This widely adopted protocol uses fixed dose steps of 5, 50, 300, and 2000 mg/kg (with 5000 mg/kg where required). Three animals of the same sex are dosed per step, and the decision to stop, repeat, or escalate the dose is based on the mortality pattern observed. Typically 6 to 12 animals are sufficient, and results directly assign a GHS acute toxicity category.
Up-and-Down Procedure (OECD TG 425)
This sequential design doses one animal at a time with a minimum 48-hour observation interval between animals. Doses progress through a geometric series (commonly 175, 550, 1750, and 5000 mg/kg), and testing stops when a statistical stopping criterion is met. The LD50 is estimated by maximum likelihood analysis using OECD-recommended statistical software, often requiring only 4 to 9 animals.
Limit Test Design
For substances expected to be of low acute toxicity, a limit test at 2000 mg/kg (or 5000 mg/kg for specific regulatory purposes) is performed. Absence of mortality and severe toxicity at the limit dose allows classification without further testing, typically using 5 animals sequentially.
Classical Statistical Methods
National standards such as GB 15193.3 and GB/T 21603 also reference conventional calculation approaches, including Horn's method using geometric dose series with tabulated confidence limits, the Bliss probit maximum likelihood method, and the Kärber area method. These remain applicable when a precise LD50 value with confidence interval is specifically required by the receiving authority.
Observation Period and Endpoint Procedures
All animals are observed intensively during the first several hours after dosing, when acute toxic signs are most likely, and at least once daily thereafter for a minimum observation period of 14 days. Clinical signs, morbidity, and mortality are recorded systematically. Animals found moribund or showing severe distress are humanely euthanized per predefined humane endpoints. All animals, including those found dead, are subjected to gross pathological examination at study termination.
Applications
Oral LD50 data generated in rats and mice support a broad range of regulatory and commercial objectives:
- GHS, CLP, and national hazard classification and labeling of chemicals
- Safety data sheet (SDS) development with acute toxicity hazard statements
- Chemical inventory notification and registration under REACH and Chinese new chemical substance regulations
- Pesticide and biocide registration dossiers for agricultural and public health products
- Food safety toxicological evaluation for additives, novel foods, and related substances
- Transport of dangerous goods hazard determination under UN recommendations
- Occupational exposure assessment and workplace hazard communication
- Pharmaceutical preclinical screening for maximum tolerated dose and dose-range finding
- Comparative potency assessment in research and development programs
FAQ
What is the difference between OECD TG 423 and OECD TG 425?
TG 423 doses three animals per dose step at fixed levels and classifies substances based on mortality patterns, while TG 425 doses single animals sequentially and applies maximum likelihood statistics to estimate a point LD50. TG 425 generally uses fewer animals but requires more time due to sequential dosing intervals.
How many animals are required for a standard study?
Modern guidelines require approximately 6 to 12 animals per species using the Acute Toxic Class or Up-and-Down Procedure, compared with 30 to 50 animals in the historical classical LD50 protocol, reflecting substantial progress in the 3Rs principle.
Which species and sex should be used?
The rat is the preferred rodent species, and many regulatory schemes recommend a second species such as the mouse for confirmation. Females are commonly used preferentially in sequential testing because available evidence suggests slightly higher sensitivity; when substantial data indicate sex differences, both sexes should be tested.
What is the standard observation period?
A minimum of 14 days after dosing is required, unless humane endpoints or regulatory criteria justify earlier termination. This period captures delayed toxicity and mortality that may occur beyond the first 24 to 48 hours.
What happens if no mortality occurs at 2000 mg/kg?
The substance is generally classified as GHS Category 5 (2000 to 5000 mg/kg) or considered unclassified for acute oral toxicity when tested at the 2000 mg/kg limit dose without mortality or severe toxic signs. Testing at 5000 mg/kg is only performed when specifically required for certain regulatory purposes.
How much sample should be submitted for testing?
For a standard two-species, single-sex study, 20 to 50 grams is typically sufficient, though the required amount increases for low-toxicity substances dosed at high levels. Accredited third-party laboratories will confirm exact quantities based on the proposed protocol design.
Can the in vivo LD50 study be waived?
Under certain regulatory frameworks, existing acute toxicity data, read-across from structurally related analogues, or validated QSAR predictions may be used to waive vertebrate testing. The accepting authority makes the final determination on whether alternative evidence fulfills the data requirement.
How are GHS oral toxicity categories assigned from LD50 values?
Category 1 corresponds to an LD50 of 5 mg/kg or less; Category 2 covers more than 5 to 50 mg/kg; Category 3 covers more than 50 to 300 mg/kg; Category 4 covers more than 300 to 2000 mg/kg; and Category 5 covers more than 2000 to 5000 mg/kg based on rat oral data.